Moderna Inc. shares declined after the company’s first-quarter vaccine sales missed estimates and it disclosed a delay in the ...

Kennedy and FDA Commissioner Marty Makary’s approach to assessing vaccines could put Covid boosters out of reach.

HHS and the National Institutes of Health are developing a project that involves producing vaccines from chemically inactivated whole viruses with the goal of making “universal” vaccines that protect ...

Supporters of Health and Human Services Secretary Robert F. Kennedy Jr. wait on stage for Kennedy and Food and Drug ...

Jefferies analysts said Moderna’s first quarter was “in line,” with a miss on revenue offset by a beat on earnings per share.

The U.S. Department of Health and Human Services (HHS) and the National Institutes for Health (NIH) today announced the ...

Measles may reestablish endemicity, with an estimated 851,300 cases over 25 years at current vaccination rates.

From STAT’s Jason Mast: Moderna said this morning in its earnings report it planned to cut costs by around $1.5 billion by ...

“Under Secretary Kennedy’s leadership, all new vaccines will undergo safety testing in placebo-controlled trials prior to ...

Public health experts worry the policy change would not only cast doubt on the safety and effectiveness of vaccines but would limit production and access. Separately, a decades-long pursuit of ...

According to the WSJ, the universal vaccine project is being pioneered by two recently appointed senior scientists in the NIH ...

Moderna is deprioritizing its flu/COVID combination vaccine in younger adults amid a push to cut about $1.5 billion from its ...